Robotic-Assisted Laparoscopic Surgery in Urogynecology and Gynecology: A Global Survey of Current Practice, Perceptions, Training and Educational Gaps

Daykan Y1, O’Reilly B2, Schraffordt S3, Rabinovich M4, Pasternak M1, O’Sullivan O2, Rotem R5

Research Type

Clinical

Abstract Category

Health Services Delivery

Abstract 95
Technologies and Devices
Scientific Podium Short Oral Session 11
Wednesday 7th October 2026
17:15 - 17:22
Parallel Hall 2
Robotic-assisted genitourinary reconstruction Questionnaire Surgery Pelvic Organ Prolapse
1. Meir Medical Center, 2. Cork University Maternity Hospital, 3. Meander Medical Center, 4. Soroka University Medical Center, 5. Cork University Maternity Hospital, Shaare Zedek Medical Center
Presenter
Links

Abstract

Hypothesis / aims of study
Robotic-assisted laparoscopic surgery (RAS) has become increasingly integrated into gynecologic and urogynecologic practice; however, global access, utilization, and training exposure remain uneven. We aimed to evaluate worldwide access to RAS, procedural use, surgeon perceptions, and training pathways among clinicians involved in gynecologic and urogynecologic surgery.
Study design, materials and methods
We conducted a cross-sectional, web-based international survey distributed through the International Urogynecological Association (IUGA) and the European Urogynaecological Association (EUGA) between April and June 2025. Surgeons, fellows, and residents performing pelvic and reconstructive procedures were eligible. The survey assessed access to robotic platforms, procedural utilization, training exposure, perceived barriers, and attitudes toward implementation. Descriptive and comparative statistical analyses were performed.
Results
A total of 1,500 clinicians were invited, and 216 participants from 49 countries completed the survey. Overall, 68.5% (148/216) reported access to at least one robotic platform. Robotic surgery was incorporated into 61.1% of gynecology departments, most commonly in urogynecology (51.9%) and gynecologic oncology (49.1%).

Among those with access, the most frequently performed procedures were hysterectomy (50.0%), sacrocolpopexy or sacrohysteropexy (44.6%), and mesh removal (19.6%). Most centers reported fewer than five robotic surgeons and relatively low annual case volumes.

Initial exposure to robotics was most commonly industry-based (14.4%). Fellowship training (20.4%), simulation (16.7%), and structured mentorship (13.4%) were considered the most effective training pathways. Among surgeons with access, 58.8% considered prior laparoscopic experience essential or highly desirable.

The main barriers to adoption were high cost (19.0%), institutional limitations (10.6%), and insufficient training opportunities (9.3%). Surgeons with robotic access were more likely to consider robotics necessary for gynecology units (40.5% vs 8.8%; p<0.001) and to recommend its use (58.1% vs 36.8%; p=0.004). Higher procedural volume was associated with stronger support for robotics (49.2% vs 22.9%; p<0.001).
Interpretation of results
RAS is widely incorporated into gynecologic and urogynecologic practice; however, access, case volume, and training exposure remain highly variable. Surgeons with access and higher procedural volume demonstrate more favorable perceptions, suggesting that experience influences attitudes toward adoption. Persistent reliance on industry-led training highlights ongoing gaps in structured, competency-based educational frameworks.
Concluding message
Although robotic-assisted surgery is increasingly utilized worldwide, disparities in access and training remain significant. Efforts should focus on developing standardized, competency-based training pathways and improving equitable access to ensure safe and effective integration of robotics into gynecologic and urogynecologic practice.
Figure 1 Global geographic distribution of survey respondents.
Figure 2 Impact of robotic platform access on surgeons’ perceptions and recommendations
Disclosures
Funding This study was not funded. Clinical Trial No Subjects Human Ethics Committee The study was approved by Meir Medical Center Ethics Committee, approval number MMC0264-25. Helsinki Yes Informed Consent Yes AI Not at all
Citation

Continence 19S (2026) 102572
DOI: 10.1016/j.cont.2026.102572

21/06/2026 00:43:38